Results:

Private and Public Partners Unite to Combat 10 Neglected Tropical Diseases by 2020

30 01 2012

Today, 13 pharmaceutical companies, the U.S., U.K. and U.A.E governments, the Bill & Melinda Gates Foundation, the World Bank and other global health organisations announced a new, coordinated push to accelerate progress toward eliminating or controlling 10 neglected tropical diseases (NTDs) by the end of the decade. Uniting efforts with NTD-endemic countries, partners pledged to […]


Pharmas Challenged by Product Risk and Philanthropy Fatigue – Covalence Pharmaceutical Industry Report 2008

9 09 2008

Increased attention on product human risk and smaller media coverage of drug donations have challenged Pharmaceuticals’ ethical reputation last year, states a report published today by Geneva-based research firm Covalence — Covalence Pharmaceutical Industry Report 2008. The pharmaceutical industry dropped from the first to the third rank of Covalence all-time EthicalQuote ranking across 10 industries. […]


Covalence Ethical Ranking 2007

2 01 2008

Geneva-based Covalence is publishing today its third annual ethical reputation ranking, giving the best ranked companies as well as those companies which have made the most progress in 2007. An overview of emerging and decreasing topics is also given. The main results across sectors are: > Rio Tinto, Dell and Marks & Spencer enter top […]


Ranking Ethique Covalence 2007

2 01 2008

La société genevoise Covalence publie aujourd’hui son troisième ranking annuel de réputation éthique, qui classe les entreprises enregistrant le meilleur score et celles ayant le plus progressé au cours de l’année 2007. Les principaux résultats à  travers les dix secteurs sont : Rio Tinto, Dell et Marks & Spencer entrent dans les 10 meilleures cotations […]


The Burden of Innovation – Covalence Pharmaceutical Industry Report 2007

29 08 2007

Pharmaceutical companies carry increasing ethical risks related to innovation, states a report released on 29 August 2007 by Geneva-based ethical reputation research firm Covalence, Covalence Pharmaceutical Industry Report 2007. These innovation-related risks deal with intellectual property rights, drug pricing, clinical trials, drug side-effects and transparency. In terms of ethical reputation, innovation seems to bring more […]


Dr Hadwen Trust: Ethical ranking of top pharma companies slammed for ignoring animal testing

1 06 2007

A report on the ethical reputations of the world’s largest pharmaceutical companies which gives UK-based multinational GlaxoSmithKline (GSK) the top score, has been heavily criticised for ignoring one of the most contentious ethical issues around, animal testing. Ethically ranking animal-testing companies without considering animal suffering is deeply misleading, says non-animal research charity, the Dr Hadwen […]


GSK, BMS, J&J top ethical ranking list by Covalence

31 05 2007

GlaxoSmithKline is at the top of ethical-monitoring firm Covalence’s ranking list, followed by Bristol-Myers Squibb and Johnson & Johnson. The quarterly report, which ranks the top 10 highest-ranking pharmas, reveals that the amount of revenue a company earns does not necessarily correspond to its ethical reputation. Pfizer, the world’s highest revenue-generating drug company, only placed […]


The Ethically Challenged: How Pharma Fares

31 05 2007

In these ethically challenging times, which drugmaker has its act together? Covalence, a research group based in Geneva that tracks ethical reputations, recently released its quarterly update in which various industrial sectors were examined. The firm compiles its rankings and charts by collecting reports – both positive and negative recent news – from the Internet […]


Ethical reputations of top pharma firms revealed

30 05 2007

The latest ethical reputations of the world’s largest pharmaceutical companies have been revealed, with GlaxoSmithKline (GSK) emerging as big pharma’s Mother Theresa, according to a recently-released compilation by Geneva-based ethical-monitoring firm Covalence. Interestingly, earning power and ethical nature do not necessarily appear to go hand in hand. Covalence has published its quarterly ethical reputation ranking, […]